Actinogen Medical Limited (AU:ACW)
ASX:ACW
Holding AU:ACW?
Track your performance easily

Actinogen Medical Limited (ACW) Income Statement

19 Followers

Actinogen Medical Limited Income Statement

Last quarter (Q4 2022), Actinogen Medical Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Actinogen Medical Limited's net income was AU$―. See Actinogen Medical Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
----AU$ 80.82K-
Cost of Revenue
------
Gross Profit
----AU$ 80.82K-
Operating Expense
-AU$ 13.17MAU$ 5.90MAU$ 8.91MAU$ 14.47MAU$ 9.56M
Operating Income
-AU$ -13.17MAU$ -5.90MAU$ -8.91MAU$ -14.47MAU$ -9.56M
Net Non Operating Interest Income Expense
-AU$ 22.59KAU$ 4.77KAU$ 65.17KAU$ 196.56KAU$ 27.26K
Other Income Expense
-AU$ 3.65MAU$ 1.98MAU$ 3.52MAU$ 4.39MAU$ 3.30M
Pretax Income
-AU$ -9.50MAU$ -3.92MAU$ -5.33MAU$ -9.89MAU$ -6.23M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -9.50MAU$ -3.92MAU$ -5.33MAU$ -9.89MAU$ -6.23M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01-
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01-
Basic Average Shares
-AU$ 1.72BAU$ 1.41BAU$ 1.14BAU$ 1.12B-
Diluted Average Shares
-AU$ 1.72BAU$ 1.41BAU$ 1.14BAU$ 1.12B-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -9.50MAU$ -3.92MAU$ -5.33MAU$ -9.89MAU$ -6.23M
Normalized Income
-AU$ -9.50MAU$ -3.92MAU$ -5.33MAU$ -9.41MAU$ -6.23M
Interest Expense
-AU$ 18.48KAU$ 22.32KAU$ 28.88KAU$ 7.99KAU$ 11.46K
EBIT
-AU$ -9.48MAU$ -3.89MAU$ -5.30MAU$ -9.88MAU$ -6.22M
EBITDA
-AU$ -9.08MAU$ -3.51MAU$ -4.89MAU$ -9.53MAU$ -5.86M
Currency in AUD

Actinogen Medical Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis